EUVIMEDEUVIMED entdecken
Crossref

Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice

Zhen-Ping Zou, Yue Du, Ting-Ting Fang, Ying Zhou, Bang-Ce Ye

Cell Host & Microbe · 2023-02 · 31 (2) · 199-212.e5

DOI: 10.1016/j.chom.2022.12.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2023-02. Verfasst von Zhen-Ping Zou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Probiotics. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid advances in synthetic biology have fueled interest in engineered microorganisms that can diagnose and treat disease. However, designing bacteria that detect dynamic disease-associated biomarkers that then drive treatment remains difficult. Here, we have developed an engineered probiotic that noninvasively monitors and records inflammatory bowel disease (IBD) occurrence and progression in real time and can release treatments via a self-tunable mechanism in response to these biomarkers. These intelligent responsive bacteria for diagnosis and therapy (i-ROBOT) consists of E. coli Nissle 1917 that responds to levels of the inflammatory marker thiosulfate by activating a base-editing system to generate a heritable genomic DNA sequence as well as producing a colorimetric signal. Fluctuations in thiosulfate also drive the tunable release of the immunomodulator AvCystatin. Orally administering i-ROBOT to mice with colitis generated molecular recording signals in processed fecal and colon samples and effectively ameliorated disease. i-ROBOT provides a promising paradigm for gastrointestinal and other metabolic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColitisProbioticsAnimalsMiceEscherichia coliThiosulfatesBacteria

Stichwörter der Autor:innen

CRISPRIBDengineered probioticssynthetic biologywhole-cell biosensor

Substanzen

Thiosulfates

Autor:innen und Institutionen

  • Laboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
  • Laboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China. Electronic address: zhouying@ecust.edu.cn.
  • Laboratory of Biosystems and Microanalysis, State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China; Institute of Engineering Biology and Health, Collabora…

Zitieren

APA

Zou, Z. P., Du, Y., Fang, T. T., Zhou, Y., & Ye, B. C. (2023). Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice. Cell Host & Microbe, 31(2), 199-212.e5. https://doi.org/10.1016/j.chom.2022.12.004

Vancouver

Zou ZP, Du Y, Fang TT, Zhou Y, Ye BC. Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice. Cell Host & Microbe. 2023;31(2):199-212.e5. doi:10.1016/j.chom.2022.12.004

BibTeX
@article{Zou2023,
  author = {Zou, Zhen-Ping and Du, Yue and Fang, Ting-Ting and Zhou, Ying and Ye, Bang-Ce},
  title = {Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice},
  journal = {Cell Host & Microbe},
  year = {2023},
  volume = {31},
  number = {2},
  pages = {199--212.e5},
  doi = {10.1016/j.chom.2022.12.004}
}
Kostenlos starten →